Loading…
← CockpitCompetitor Analysis › ARX Accelerant Holdings Class AOpen in the cockpit ↗

Accelerant Holdings Class AARXCompetitor analysis, valuation and peers

United States · USD·Financials›Property/Casualty Insurance

Runs a risk-exchange platform connecting specialty insurance underwriters (MGAs) with reinsurance capital providers.

Momentum strong 74
Mkt cap
$4.17B
US dollars, full cap
Free float
50%
of shares outstanding
$/day
$18.7M
20-day average traded
P/B
5.91×
price to book
ROE
8.6%
delivered
Implied ROE
24.1%
what the price asks
Next earnings
126 days
24 Mar 2027
Close · USD$19.90
1D+0.2%
1W+0.1%
1M+0.7%
3M+1.7%
6M+19.2%
YTD+21.7%
1Y+53.9%
ATR %0.3%
Beta0.26
52w lowhigh0.1% off high

What Accelerant does

Runs a risk-exchange platform connecting specialty insurance underwriters (MGAs) with reinsurance capital providers.

Takes fees on the insurance premium its member underwriters place through the exchange, so premium volume and the number of members drive revenue. Members are small specialty underwriters, called MGAs, that write policies on an insurer's behalf; risk capital comes from outside reinsurers and institutional investors who choose which business to back.

Products and services

  • Member underwriting network
  • Risk-capital placement/reinsurance access
  • Underwriting analytics/data

Customers

  • Specialty MGAs ("Members")
  • Reinsurers/institutional risk capital

Where it sits in the supply chain

  • Insurance infrastructure
  • MGA risk-underwriting network
  • Risk-capital/reinsurance matching…

What could go right

  • Growth in specialty/E&S insurance demand
  • New Member and capital-provider additions

What could go wrong

  • Newly public, unproven through a hard reinsurance cycle
  • Concentration risk in key Members/capital providers

Moat: narrow (network effects, data). A growing two-sided network of underwriters and capital providers is hard for new entrants to replicate quickly.

Headquarters: Hamilton, Bermuda · Founded: 2018

Named competitors

Accelerant at a glance

Size Accelerant (ARX) is a United States Financials company (Property/Casualty Insurance) with a market value of $4.17B, the 1312th largest of 3,085 United States companies the cockpit tracks. Shares closed at $19.90 on 18 Nov 2026.

Performance Over six months the shares gained 19.2%, against +10.3% for the median peer and -2.2% for the United States market (cap-weighted) — 8th highest of 21 in its peer set.

Growth Revenue grew 54.6% over the last twelve months (peer median +5.2%); the operating margin is 18.9% (peer median 14.7%).

Valuation It trades at 5.91× book value against a peer median of 1.77× (3rd most expensive of 21).

Price implies The share price implies a return on equity of about 24.1%; Accelerant delivers 8.6%, so the price asks more than the business earns today.

Short interest Short interest is 2.5% of the free float (30 Oct 2026).

Next results Next results expected around 24 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010012021 May 202621 Aug 202618 Nov 2026ARX 117Peer median 111
Six months, rebased to 100: Accelerant against the median of its 20 peers (local-currency closes).

Accelerant financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$821M$517M$334M$162M$174M
Revenue growth—+55%+106%-7%—
Net income$60.6M-$1.35B$27.2M-$48.8M-$91.7M
Capital expenditure$47.4M$41.4M$34.4M$32.6M$26.7M
Total debt$120M$121M$121M$120Mn/a

Quarterly statements and history in the cockpit →

Accelerant competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

0%+20%+40%-10%0%+10%PLMRPROTMCYMTGHGTYSPNTNMIHDFYSIGI7164PRCHHCIHMNTHG001450KMPR2850SAFTARX6-month return →1-month return →
Up and to the right = strong over both horizons. Accelerant is the large dot.

Fundamentals: return on equity against price-to-book

-20%0%20%00×2.50×50×7.50×PLMRPROTMCYMTGHGTYSPNTNMIHDFYSIGIHCIHMNLRETHG001450KMPRSAFTARXReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Accelerant is the large dot.

Capital: ROE delivered against the ROE the price implies

-20%0%20%40%-20%0%20%40%PLMRPROTMCYMTGHGTYSPNTNMIHDFYHCILRE001450KMPR2850SAFTARXROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Accelerant is the large dot.

Accelerant competitors and peer comparison

Head to head with its named competitors (ARX vs RYAN vs SKWD vs BRO)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Accelerant ARX$4.17B+19%+55%9%5.91×24.1%
Ryan Specialty RYAN$12.2B+46%+9%19%13.04×64.9%
Skyward Specialty Insurance SKWD$2.82B+34%+35%17%2.21×11.0%
Brown & Brown BRO$24.2B+27%+26%10%1.89×11.8%

How Accelerant compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Accelerant against its 20 peers (data as of 18 Nov 2026)
MeasureARXPeer medianRank in peer set
1-month return+0.7%+3.1%10th lowest of 21
6-month return+19.2%+10.3%8th highest of 21
Return on equity8.6%15.1%5th lowest of 20
Price / book5.91×1.77×3rd most expensive of 21
Trailing P/E72.2×12.0×3rd most expensive of 19
ROE the price implies24.1%9.8%3rd most demanding of 21
ROE delivered8.6%15.1%5th lowest of 20

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Accelerant ARXUnited States$4.17B+19%+55%9%5.91×24.1%8.6%
Palomar PLMRUnited States$4.14B+36%+59%23%4.20×18.0%23.3%
Protector Forsikring PROT.OLNorway$4.02B+2%+12%35%5.36×18.4%35.2%
Mercury General MCYUnited States$4.64B-19%+5%26%1.65×14.2%25.5%
MGIC Investment MTGUnited States$5.37B+2%-2%14%1.12×8.9%13.8%
Hagerty HGTYUnited States$5.57B+47%+1%5%7.60×50.3%4.6%
SiriusPoint SPNTUnited States$2.98B+9%+18%23%1.34×9.8%22.6%
NMI NMIHUnited States$2.88B+1%+7%15%1.09×8.1%15.1%
Definity Financial DFY.TOCanada$6.08B+4%+37%6%2.08×7.8%5.9%
Selective Insurance SIGIUnited States$6.12B+16%+4%15%1.88×9.7%14.7%
Zenkoku Hosho 7164.TJapan$2.72B+7%+2%14%1.74×6.3%13.9%
Scor SCR.PAFrance$6.88B+10%-4%19%1.45×10.0%18.8%
Porch PRCHUnited States$2.37B+113%+20%n/a363.13×6,199.4%n/a
HCI HCIUnited States$2.37B+21%+20%34%2.12×17.5%33.8%
Horace Mann Educators HMNUnited States$2.15B+13%+4%12%1.51×8.4%12.4%
Lancashire LRE.LUnited Kingdom$2.08B+2%-2%22%1.41×12.4%21.8%
Hanover Insurance THGUnited States$8.42B+26%+5%22%2.45×11.7%21.8%
Hyundai M&F INS 001450.KSSouth Korea$1.97B+10%+10%13%0.44×4.1%13.1%
Kemper KMPRUnited States$1.93B+11%-8%-17%0.90×9.6%-17.4%
Shinkong Insurance 2850.TWTaiwan$1.57B+25%+22%24%2.35×6.7%24.0%
Safety Insurance SAFTUnited States$1.53B+43%+5%8%1.79×9.4%8.0%

Questions

Who are Accelerant's main competitors?
Named competitors: Ryan Specialty Group (RYAN), Lloyd's of London (private or unlisted), Skyward Specialty Insurance (SKWD), Brown & Brown (BRO). The cockpit's measured peer set (industry) also includes Palomar (PLMR), Protector Forsikring (PROT.OL), Mercury General (MCY), MGIC Investment (MTG), Hagerty (HGTY), SiriusPoint (SPNT).
Is Accelerant expensive compared with its peers?
On price / book it trades at 5.91× against a peer median of 1.77×, 3rd most expensive of 21 in its peer set. The share price implies a return on equity of about 24.1%; Accelerant delivers 8.6%, so the price asks more than the business earns today.
How has Accelerant stock performed?
Over six months to 18 Nov 2026 the shares returned +19.2% against +10.3% for the median peer; over one year +53.9%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.